Variable | Incipient caries (ICDAS 1 to 2) | Advanced caries (ICDAS 3 to 6) | ||||
---|---|---|---|---|---|---|
 | B (SE) | IRR (95%CI) | p | B (SE) | IRR (95% CI) | p |
Sex | Â | Â | Â | Â | Â | Â |
Male | 0.11 (0.16) | 1.12 (0.82–1.51) | 0.47 | 0.09 (0.17) | 1.09 (0.77–1.55) | 0.61 |
Female | 0a | Â | Â | 0a | Â | Â |
Comparison versus experimental; group | Â | Â | Â | Â | Â | Â |
Experimental group | − 0.23 (0.15) | 0.80 (0.59–1.07) | 0.13 | − 0.38 (0.17) | 0.67 (0.48–0.95) | 0.02 |
Comparison group | 0a | Â | Â | 0a | Â | Â |
Baseline caries status | 0.01 (0.01) | 1.01 (0.99–1.02) | 0.31 | 0.02 (0.01) | 1.02 (1.01–1.04) | 0.02 |
Salivary pH at baseline | − 0.12 (0.20) | 0.88 (0.60–1.30) | 0.53 | − 0.02 (0.22) | 0.97 (0.63–1.50) | 0.91 |
Salivary flowrate per minute at baseline | 0.08 (0.18) | 1.08 (0.76–1.53) | 0.66 | − 0.86 (0.22) | 0.43 (0.27–0.65) | 0.000 |
Total buffering capacity at baseline | − 0.05 (0.05) | 0.95 (0.86–1.05) | 0.35 | 0.06 (0.05) | 1.06 (0.95–1.18) | 0.27 |
Salivary MS levels at baseline | Â | Â | Â | Â | Â | Â |
 ≥ 10^5 CFU/ml saliva | 0.42 (0.19) | 1.53 (1.03–2.24) | 0.03 | 0.50 (0.23) | 1.66 (1.04–2.65) | 0.03 |
 < 10^5 CFU/ml saliva | 0a |  |  | 0a |  |  |
Salivary LB levels at baseline | Â | Â | Â | Â | Â | Â |
 ≥ 10^5 CFU/ml saliva | 0.35 (0.18) | 1.42 (0.99–2.05) | 0.06 | 0.61 (0.21) | 1.84 (1.20–2.80) | 0.004 |
 < 10^5 CFU/ml saliva | 0a |  |  | 0a |  |  |
Salivary yeast counts | Â | Â | Â | Â | Â | Â |
Moderate or heavy | 0.03(0.24) | 0.97 (0.60–1.56) | 0.90 | − 0.42(0.31) | 0.65 (0.35–1.18) | 0.16 |
None or light | 0a | Â | Â | 0a | Â | Â |